Federal authorities are investigating a Centennial biotech company for allegedly defrauding at least 151 investors of more than $10 million by misleading them about new technology to diagnose and treat lung cancer and cardiovascular disease.
However, Brimmer said he didn’t freeze the company’s assets as the SEC wanted because “defendants do not currently have any significant assets that could be frozen.” The SEC’s lawsuit names Greg Colip of Spring, Texas, Cell>Point’s co-founder and CEO, and his brother, Terry Colip of Greenwood Village, co-founder and chief financial officer. It covers the company’s activities from January 2016 through February 2021.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: